20
Participants
Start Date
February 5, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
January 31, 2026
CSB-001 Ophthalmic Solution 0.1%
CSB-001: human recombinant dHGF (5-amino acid deleted hepatocyte growth factor)
RECRUITING
Virginia Eye Consultants, Norfolk
RECRUITING
Francis Price Jr, MD, Indianapolis
RECRUITING
Midwest Cornea Associates, LLC, Carmel
RECRUITING
Minnesota Eye Consultants, Minnetonka
RECRUITING
Stuart A. Terry, MD PA, San Antonio
RECRUITING
Loma Linda University Eye Institute, Loma Linda
RECRUITING
Legacy Devers Eye Institute, Portland
Lead Sponsor
Claris Biotherapeutics, Inc.
INDUSTRY